scholarly journals Willingness To COVID-19 Vaccination: Empirical Evidence From EU

Author(s):  
Imran Ur Rahman ◽  
Arslan Austin ◽  
Naveed Nelson

Abstract The unforgettable COVID-19 shock can only be reversed by a viable vaccination strategy. In this paper, we investigate willingness to be vaccinated (WTV) against the COVID-19. We provide first of its kind empirical evidence on the citizens (N=11,932) of the EU-27 by employing the recent data from the European Commission. Controlling for the correlations in the error terms, we utilize a simulated multivariate probit regression model. Our results show that amongst all the statistically significant drivers of the WTV, the positive perception (vaccination works and has no side effects); R&D information (clarity on how vaccination is developed, tested, authorized) has the largest impact on the WTV. We find that the group of variables on social feedback, and on trustworthy sources of information are to be considered for WTV policy. The counteracting policy gaps are also identified. Our work is novel and has implications for COVID-19 vaccination policies across the EU.

Data ◽  
2021 ◽  
Vol 6 (1) ◽  
pp. 3
Author(s):  
Irene López-Rodríguez ◽  
César F. Reyes-Manzano ◽  
Israel Reyes-Ramírez ◽  
Tania J. Contreras-Uribe ◽  
Lev Guzmán-Vargas

Quantitative and qualitative data on active-ingredient drug composition are essential information for characterizing near-field exposure of consumers to product-related chemicals, among other things. Equally as important is the characterization of the relationship between one or many active ingredients in terms of the diseases they are prescribed for. Such evaluations, however, require quantitative information at different anatomical levels. To complement the available sources of information on active substances and diseases, we have designed a database with enough versatility to potentially be used in a variety of analyzes. By using information provided by a well-established online pharmacological dictionary, we present a database with 11 tables which are easy to access and manipulate. Specifically, we present datasets containing the details of 12,827 marketed drug products, 40,164 diseases, 6231 active pharmaceutical ingredients and 4093 side effects. We exemplify the usefulness of our database with three simple visualizations, which confirm the importance of the data for quantifying the complexity in the associations among active substances, diseases and side effects. Although there are databases with detailed information on active substances and diseases, none of them can be found in Spanish. Our work presents an option that contributes substantially to obtaining well classified information in order to evaluate the roles of active pharmaceutical ingredients, diseases and side effects. These datasets also provide information about clinical and pharmacological groupings which may be useful for clinical and academic researchers. The database will be regularly updated and extended with the newly available Virtual Medicinal Products.


2003 ◽  
Vol 36 (1-2) ◽  
pp. 41-74 ◽  
Author(s):  
Simon Hug

The interplay among intergovernmental and supranational actors is a defining feature of the institutional life of the European Union (EU). Too often, however, these actors are considered independent of each other, and their autonomy is assessed in a vacuum. This is problematic because if there is such a thing as "endogenous preferences" in the EU, it appears exactly through this interdependence of intergovernmental and supranational actors. None of the institutionalist approaches to the EU has come to grips with this fact yet. Based on some very simple gametheoretic ideas, I offer in this article a rationale for "endogenous preferences" and discuss their impact on issues of delegations. Some cursory empirical evidence supports the claims that the preferences of supranational actors are related to those of the actors who select or appoint them. Similarly, the analyses presented here suggest that preferences over delegation to supranational actors are influenced by differences in policy views between principals and agents.


2006 ◽  
Vol 10 (S1) ◽  
pp. S173b-S173 ◽  
Author(s):  
T. Bell ◽  
T. Milanova ◽  
G. Grove ◽  
R. Williamson ◽  
S. Bolge
Keyword(s):  

2020 ◽  
Vol 28 (2) ◽  
pp. 325-342
Author(s):  
Olga Salido ◽  
Julio Carabaña

This article was inspired by Atkinson and Brandolini’s work on the economic middle classes and deals with the evolution of the income share of the middle class compared with that of the extreme classes in the EU-15 (the EU’s first 15 member states) over the last two decades. Our research draws on the paradox of the EU officially assuming dominant ideas about rising inequalities and the squeezing of middle-class income produced by globalization and technological change while at the same time producing and disseminating empirical evidence contrary to this view. We first synthesize this evidence, also contributing some additional analyses of Eurostat data, confirming that the income share of the middle class has not changed in the past two decades, as could be expected from the invariance in income inequality. We finally put forward some considerations about the theoretical implications of these empirical results and the interaction between ideas and empirical evidence in political societies and organizations.


2019 ◽  
Vol 21 (6) ◽  
pp. 1307-1324 ◽  
Author(s):  
Nicholas Martin ◽  
Christian Matt ◽  
Crispin Niebel ◽  
Knut Blind

AbstractWhile many data-driven businesses have seen rapid growth in recent years, their business development might be highly contingent upon data protection regulation. While it is often claimed that stricter regulation penalizes firms, there is only scarce empirical evidence for this. We therefore study how data protection regulation affects startup innovation, exploring this question during the ongoing introduction of the EU General Data Protection Regulation (GDPR). Our results show that the effects of data protection regulation on startup innovation are complex: it simultaneously stimulates and constrains innovation. We identify six distinct firm responses to the effects of the GDPR; three that stimulate innovation, and three that constrain it. We furthermore identify two key stipulations in the GDPR that account for the most important innovation constraints. Implications and potential policy responses are discussed.


Public Choice ◽  
2012 ◽  
Vol 156 (3-4) ◽  
pp. 423-441 ◽  
Author(s):  
Jakob de Haan ◽  
Richard Jong-A-Pin ◽  
Jochen O. Mierau

2017 ◽  
Vol 28 (1) ◽  
pp. 6-12 ◽  
Author(s):  
Julia H. Littell ◽  
Howard White

In this article, we trace the development of the Campbell Collaboration and its renewed efforts to build a world library of accurate, synthesized evidence to inform policy and practice and improve human well-being worldwide. Campbell systematic reviews and related evidence synthesis products provide unbiased summaries of entire bodies of empirical evidence, making them uniquely useful sources of information for policy and practice. With recent changes in organizational structure and new leadership, the Campbell Collaboration is poised to dramatically increase the production, dissemination, and use of rigorous syntheses of research on social, economic, and behavioral interventions. Campbell provides opportunities for social work scholars, practitioners, and consumers to contribute to knowledge about the processes and outcomes of social, behavioral, and economic interventions.


Sign in / Sign up

Export Citation Format

Share Document